| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/24/2003 | US20030078517 In vivo delivery methods and compositions |
| 04/24/2003 | US20030078442 Crystalline base of citalopram |
| 04/24/2003 | US20030078440 O- or S- substituted tetrahydronaphthalene derivatives useful as regulators of cell proliferation and differentiation, useful for treating skin-related diseases |
| 04/24/2003 | US20030078438 N-heterocyclicamide compounds; used as anticoagulant agent |
| 04/24/2003 | US20030078434 An aromatic sulfonamide compound for treating glomerulonephritis and diabetic nephropathy, having a superior antiproteinuric effect and superior inhibitory activity for type IV collagenase |
| 04/24/2003 | US20030078432 Novel benzotriazoles anti-inflammatory compounds |
| 04/24/2003 | US20030078431 Biheterocyclic compounds having high anticoagulant activity, used as inhibitors of factor Xa |
| 04/24/2003 | US20030078427 Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 04/24/2003 | US20030078426 Thiazolidine or oxazolidine compounds useful for preventing or therapeutical agents for various diseases such as diabetes and hyperlipemia |
| 04/24/2003 | US20030078420 New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 04/24/2003 | US20030078419 For therapy of autoimmune diseases mediated by cathepsin S; for inhibiting the progression of tissue transplant rejection |
| 04/24/2003 | US20030078418 Useful potentiators of beta -lactam antibiotics; therapy |
| 04/24/2003 | US20030078417 For protecting cells from injury due to intrinsic membrane lysis, oxidation and/or invasion by destructive agents; for therapy of phospholipase mediated injury, injury due to oxidation, and inflammation |
| 04/24/2003 | US20030078409 Nucleotide sequences coding polypeptide for use in the treatment of respiratory system, asthmatic and inflammatory bowel diseases |
| 04/24/2003 | US20030078405 47 human secreted proteins |
| 04/24/2003 | US20030078376 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 04/24/2003 | US20030078373 Chaperone fragments |
| 04/24/2003 | US20030078365 Novel polymers for delivering nitric oxide in vivo |
| 04/24/2003 | US20030078304 Administering to animal or man of at least one type of xanthophyll in an amount inhibiting the expression of inflammatory cytokines and chemokines in animal or man |
| 04/24/2003 | US20030078303 Methods of treating and preventing sexual dysfunction using (+) sibutramine in combination with phosphodiesterase inhibitors |
| 04/24/2003 | US20030078302 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
| 04/24/2003 | US20030078300 Fused bicyclic or tricyclic amino acids |
| 04/24/2003 | US20030078299 Anti-cancer nitro- and thia-fatty acids |
| 04/24/2003 | US20030078296 Methods for inhibiting angiogenesis and tumor growth |
| 04/24/2003 | US20030078295 Method for treating multiple sclerosis |
| 04/24/2003 | US20030078294 For therapy of emphysema and/or bronchopulmonary dysplasia in a mammal |
| 04/24/2003 | US20030078293 Administering etodolac for therapy of prostate cancer in a mammals |
| 04/24/2003 | US20030078292 Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis |
| 04/24/2003 | US20030078291 Novel compound having antimalarial activity |
| 04/24/2003 | US20030078289 Indole carboxylic acids as thyroid receptor ligands |
| 04/24/2003 | US20030078288 Indole derivatives |
| 04/24/2003 | US20030078286 For therapy of central nervous system disorders such as anxiety, depression, motor disorders |
| 04/24/2003 | US20030078285 Liquid for oral administration comprising paroxetine |
| 04/24/2003 | US20030078284 Materials and methods for the treatment of depression |
| 04/24/2003 | US20030078283 Administering diethyl lactams such as 3,3-diethyl-2-pyrrolidinone for inducing anesthesia or conscious sedation |
| 04/24/2003 | US20030078282 For therapy of allergic dermatitis and atopy in animals and humans |
| 04/24/2003 | US20030078281 Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agents |
| 04/24/2003 | US20030078280 Macroheterocylic compounds useful as kinase inhibitors |
| 04/24/2003 | US20030078279 For therapy and prophylaxis of pain, central nervous system disorder or the like in mammalian subjects |
| 04/24/2003 | US20030078278 Spiropiperidine compounds as ligands for ORL-1 receptor |
| 04/24/2003 | US20030078276 Matrix metalloproteinase inhibitors |
| 04/24/2003 | US20030078275 For therapy of cancer, diabetes and Alzheimer's disease |
| 04/24/2003 | US20030078274 Method of reducing neuronal injury or apoptosis |
| 04/24/2003 | US20030078273 Heterocyclic amine, a phenylazacycloalkane, a cabergoline, or an aromatic bicyclic amine active agent |
| 04/24/2003 | US20030078272 Modulating metabolism of ciprofloxacin-resistant and/or Streptococcus pneumoniae with a gemifloxacin compound |
| 04/24/2003 | US20030078271 Pyrimidine and indolone derivatives |
| 04/24/2003 | US20030078270 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 04/24/2003 | US20030078269 Biguanide and sulfonylurea formulations for the prevention and treatment of insulin resistance and type 2 diabetes mellitus |
| 04/24/2003 | US20030078268 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene |
| 04/24/2003 | US20030078266 Powder of 30-90% a water-soluble cycloxygenase inhibitor, 5-60% of a buffer and 0-10% of other excipients |
| 04/24/2003 | US20030078265 Inhibitors of nitric oxide synthase (nos) |
| 04/24/2003 | US20030078263 Nonnucleotide compounds which interact with specific structures of dna; anticancer agents |
| 04/24/2003 | US20030078262 Single dose of reboxetine and pindolol; noradrenaline reuptake inhibitors |
| 04/24/2003 | US20030078261 Prostaglandin agonists |
| 04/24/2003 | US20030078260 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 04/24/2003 | US20030078259 Nicotinic acetylcholine receptor activators; treating neurodegenerative disorders |
| 04/24/2003 | US20030078258 Adrenergic blocking agents |
| 04/24/2003 | US20030078257 Methods of treating tumors |
| 04/24/2003 | US20030078254 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 04/24/2003 | US20030078252 Used to treat abnormal cell growth and central nervous system disorders |
| 04/24/2003 | US20030078248 Treating ischemic disease, cardiac arrhythmias, chronic pain, inducing sleep in a mammal |
| 04/24/2003 | US20030078247 Enzyme inhibitor of a dipeptidyl peptidase for treating hyperglycaemia |
| 04/24/2003 | US20030078246 Combinations for the treatment of inflammatory disorders |
| 04/24/2003 | US20030078245 Progestogen-anti-progestogen regimens |
| 04/24/2003 | US20030078244 Regulation of intracellular glucocorticoid concentrations |
| 04/24/2003 | US20030078243 Concentrated water-dispersible vitamin compositions |
| 04/24/2003 | US20030078241 Treating effects of excessive reactive oxygen species |
| 04/24/2003 | US20030078239 Ketone compounds and compositions for cholesterol management and related uses |
| 04/24/2003 | US20030078238 Stabilization method of nano-sized emulsion using tocopheryl derivatives and external application for skin containing the same |
| 04/24/2003 | US20030078236 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 04/24/2003 | US20030078235 Treatment of central nervous system disorders; anticonvulsants, antiepileptics, neuroprotective agents and muscle relaxants |
| 04/24/2003 | US20030078234 Applying semi-crystalline acetylglucosamine polysaccharide for treating vasoconstriction, reduction in blood flow |
| 04/24/2003 | US20030078233 A red microalga polysaccharide; able inhibiting the replication of virus |
| 04/24/2003 | US20030078232 A stimulants for bone marrow cell proliferation, countering the toxic side effect of drugs, in particular chemotherapeutic drugs, such as leukopenia and neutropenia |
| 04/24/2003 | US20030078223 Administering to individual first dose of composition comprising an immunomodulatory nucleic acid and after suitable time administering second dose of composition comprising an immunomodulatory nucleic acid; antiasthmatics |
| 04/24/2003 | US20030078215 Wherein biological activity of bioactive agent/complexing agent complex is higher than activity of uncomplexed bioactive agent |
| 04/24/2003 | US20030078214 Phytooestrogen selected from genistein, daidzein; for promoting health in cases of cancer, pre-menstrual syndrome, menopause or hypercholesterolaemia |
| 04/24/2003 | US20030078213 Administering pharmaceutical composition comprising a sulfamate |
| 04/24/2003 | US20030078212 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same |
| 04/24/2003 | US20030078209 Porous composition, substantially insoluble in water, comprising 25% by weight oxidised cellulose and exhibiting a significant capacity to remove iron from aqueous environment; treatment of infections by iron-requiring microorganisms |
| 04/24/2003 | US20030078196 Administering cisplatin; drug delivery; reduced dosage to prevent release into systemic circulation |
| 04/24/2003 | US20030078193 Therapeutic Agents For Diabetes |
| 04/24/2003 | US20030078190 Methods for tissue protection using highly effective inhibition of the renin-angiotensin system |
| 04/24/2003 | US20030078189 Medicinal compositions for oral use |
| 04/24/2003 | US20030078166 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | US20030077808 Nucleotide sequences coding polypeptide for use in the diagnosis of cancer |
| 04/24/2003 | US20030077749 Ucp5 |
| 04/24/2003 | US20030077700 Nucleotide sequences coding polypeptide for use in the treatment of tumors, nervous system amd liver disordrs |
| 04/24/2003 | US20030077661 ATM kinase compositions and methods |
| 04/24/2003 | US20030077650 Functionalized silicon compounds and methods for their synthesis and use |
| 04/24/2003 | US20030077638 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 04/24/2003 | US20030077614 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 04/24/2003 | US20030077602 Nucleic acids, proteins, and antibodies |
| 04/24/2003 | US20030077585 Nucleotide sequences coding polypeptide for use in the diagnosis, detection, prevention and treatment of bacterial infection |
| 04/24/2003 | US20030077568 Screening drugs; obtain cell with preferential phenotypic profile, incubate with drug, monitor effect on cells |
| 04/24/2003 | US20030077564 Amplification of neural cell viability in brain or spinal cord tissue after brain or spinal cord injury; obtain tissue, apply nutrient broth, monitor cell viability |
| 04/24/2003 | US20030077342 Anti-inflammatory complex containing eicosapentaenoic acid |
| 04/24/2003 | US20030077340 Lipid is coconut oil esterified with fatty acid |
| 04/24/2003 | US20030077339 Plant extract for diabetic therapy |
| 04/24/2003 | US20030077336 Anti-inflammatory complex containing flaxseed oil |